Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06565312 · ClinicalTrials.gov registry record · NA
A Single Group Study to Evaluate the Effects of a Probiotic Vaginal Suppository on Vaginal Health.
A NA study of Vaginal Health and Vaginal pH, sponsored by Love Wellness.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06565312: Completed NA study of Vaginal Health and Vaginal pH, sponsored by Love Wellness.
NCT06565312 is a NA study of Vaginal Health and Vaginal pH that has completed, run by Love Wellness. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06565312, a NA study of Vaginal Health and Vaginal pH, has completed, sponsored by Love Wellness.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a virtual single-group clinical trial lasting 8 weeks to evaluate the effects of a probiotic vaginal suppository on vaginal health. Participants will use the Flora Power suppository daily for 5 consecutive days when experiencing common signs of vaginal imbalance. They will complete questionnaires and vaginal pH tests before and after product use.
Primary Outcome
Measure the change in vaginal pH levels with a test strip from baseline to 24 hours after the 5-day intervention period.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Flora Power Probiotic Vaginal Suppository
Study Locations (1)
California
- Citruslabs - Santa Monica
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-05-10 |
| Est. Completion | 2024-07-10 |
| Phase | NA |
What the finished NCT06565312 record still lists
NCT06565312 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Vaginal Health appearing as the primary indexed condition, and to 1 intervention - of which Flora Power Probiotic Vaginal Suppository is the first listed.
NCT06565312 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06565312 about?
NCT06565312 is a clinical study titled "A Single Group Study to Evaluate the Effects of a Probiotic Vaginal Suppository on Vaginal Health.". This is a virtual single-group clinical trial lasting 8 weeks to evaluate the effects of a probiotic vaginal suppository on vaginal health. Participants will use the Flora Power suppository daily for 5 consecutive days when experiencing common signs of vaginal imbalance. They will complete questionn...
What is the current status of trial NCT06565312?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2024-05-10. Estimated completion is 2024-07-10.
What conditions does trial NCT06565312 study?
This clinical trial studies the following conditions: Vaginal Health, Vaginal pH.
What interventions are being tested in trial NCT06565312?
The interventions under investigation include: Flora Power Probiotic Vaginal Suppository (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06565312?
This trial is sponsored by Love Wellness, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06565312 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06565312's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI